ArticleClinicoEconomics and outcomes research : CEOR2025
Healthcare Utilization and Cost in the Two Years Before Neuromodulation Implantation Among Medicaid Enrollees with Drug-Resistant Epilepsy.
Kathryn Evans et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.